Hims & Hers Health (NYSE: HIMS), the telehealth company famous for selling Ozempic lookalikes over the internet, is tumbling ...

What To Know: The company reported sales of $544.83 million, missing the consensus estimate of $549.82 million, but representing a 73% year-over-year increase. In addition, the company reported ...

Discover key insights from Frontdoor's Q2 2025 earnings, including 14% revenue growth, upgraded guidance, and record profitability.

A new 50% tariff on Brazilian coffee imports could squeeze Starbucks' margins and force the company to rethink its supply ...

Pfizer boosted its profit outlook for the year following gains to its top- and bottom-line in its latest quarter.

Arcutis Biotherapeutics Inc (NASDAQ:ARQT) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for ...

ACRE's chronic loan defaults and poor underwriting make it the top mortgage REIT to avoid, despite recent distribution cuts.